Orphan Drug Designation: requests content and format; notifications of changes; deficiency letters; annual reports; assurance of sufficient quantities; meeting requests

Orphan Drugs

OMB: 0910-0167

IC ID: 5770

Information Collection (IC) Details

View Information Collection (IC)

Orphan Drug Designation: requests content and format; notifications of changes; deficiency letters; annual reports; assurance of sufficient quantities; meeting requests
 
No Modified
 
Mandatory
 
21 CFR 316.12 21 CFR 316.14 21 CFR 316.10 21 CFR 316.20 21 CFR 316.21 21 CFR 316.22 21 CFR 316.24 21 CFR 316.22 21 CFR 316.27 21 CFR 316.30 21 CFR 316.36

Document Type Form No. Form Name Instrument File URL Available Electronically? Can Be Submitted Electronically? Electronic Capability
Other-Guidance 0167 Guidance-Meetings with OPD.pdf Yes Yes Fillable Fileable
Form and Instruction FDA 4035 FDA Orphan Drug Designation Request Form 0167 FDA-4035.pdf Yes Yes Fillable Fileable

Health Consumer Health and Safety

 

4,577 0
   
Private Sector Businesses or other for-profits
 
   0 %

  Approved Program Change Due to New Statute Program Change Due to Agency Discretion Change Due to Adjustment in Agency Estimate Change Due to Potential Violation of the PRA Previously Approved
Annual Number of Responses for this IC 4,577 0 4,576 0 0 1
Annual IC Time Burden (Hours) 123,673 0 123,623 0 0 50
Annual IC Cost Burden (Dollars) 0 0 0 0 0 0

Title Document Date Uploaded
No associated records found
            Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.

© 2024 OMB.report | Privacy Policy